极早产儿和超早产儿生后早期有血流动力学意义动脉导管未闭闭合的影响因素研究
Study on the influence factors for hemodynamically significant patent ductus arteriosus in the early life after birth of very preterm and extremely preterm infants
Received date: 2023-11-17
Online published: 2024-10-08
目的 探讨影响极早产儿和超早产儿生后早期有血流动力学意义的动脉导管未闭(hsPDA)闭合的影响因素。方法 对2016年11月至2022年3月出生孕周<32周的172例伴有hsPDA的极早产儿和超早产儿进行回顾性分析,并根据出生后2周超声心动图复查结果分为PDA关闭组(n=83)和PDA组(n=89)。收集两组早产儿的临床资料进行病例对照研究。结果 单因素分析结果显示,hsPDA发生与PDA大小、胎龄、出生体重、1分钟Apgar评分、自然受孕、产前地塞米松、产前硫酸镁、妊娠期糖尿病、早产胎膜早破有关(P<0.05)。多因素logistic回归分析显示自然受孕、产前地塞米松和硫酸镁应用有利于hsPDA关闭,PDA内径较大、出生体重低和妊娠期糖尿病不利于hsPDA关闭(P<0.05)。结论 早期识别临床高危因素可以对极早产儿和超早产儿生后早期hsPDA进行危险预警,从而为早产儿hsPDA个体化治疗提供参考。
关键词: 有血流动力学意义的动脉导管未闭; 高危因素; 早产儿
王珊珊 , 赵普 , 黄丽萍 , 胡雪峰 , 李菁 . 极早产儿和超早产儿生后早期有血流动力学意义动脉导管未闭闭合的影响因素研究[J]. 临床儿科杂志, 2024 , 42(10) : 863 -867 . DOI: 10.12372/jcp.2024.23e1120
Objective This study aimed to identify influence factors of hemodynamically significant patent ductus arteriosus (hsPDA) in very preterm and extremely preterm infants during the early postnatal period. Methods A retrospective analysis of 172 very preterm and extremely preterm infants were conducted from November 2016 to March 2022. Infants were categorized into a PDA closure group (n=83) and a PDA persistence group (n=89), based on the PDA diameter approximately two weeks after birth. Clinical data, including obstetric factors and the infants' conditions at birth, treatment, and complications, were analyzed using univariate and logistic regression methods. Results Univariate analysis indicated that hsPDA was correlated with PDA size, gestational age, birth weight, 1-minute Apgar score, natural conception, prenatal dexamethasone, prenatal magnesium sulfate, maternal gestational diabetes, and premature rupture of membranes (P < 0.05). Logistic regression identified natural conception, prenatal dexamethasone, and magnesium sulfate were helpful for PDA closure, while a large PDA diameter, low birth weight, and maternal gestational diabetes were significant risk factors for hsPDA persistence. Conclusion Clinical predictors can significantly aid in the early recognition of infants at high risk for hsPDA, guiding timely treatment strategies.
[1] | 赵彩艳, 孙玄, 陈玲. 早产儿血流动力学显著的动脉导管未闭危险因素和预测指标研究进展[J]. 临床儿科杂志, 2023, 41(6): 475-479. |
[2] | Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics, 2020, 146(5): e20201209. |
[3] | Hundscheid T, Onland W, Kooi EMW, et al. Expectant management or early ibuprofen for patent ductus arteriosus[J]. N Engl J Med, 2023, 388: 980-990. |
[4] | Mitra S, Boode WP, Weisz DE, et al. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews[J]. Cochrane Database Syst Rev, 2020(4): CD013588. |
[5] | Wei YJ, Hsu R, Lin YC, et al. The association of patent ductus arteriosus with inflammation: a narrative review of the role of inflammatory biomarkers and treatment strategy in premature infants[J]. Int J Mol Sci, 2022, 23(22): 13877. |
[6] | Chen YX, Xiao TT, Chen HY, et al. Risk stratification of hemodynamically significant patent ductus arteriosus by clinical and genetic factors[J]. World J Pediatr, 2023, 19: 1192-1202. |
[7] | Gillam-Krakauer M, Reese J. We still don't know when to close a patent ductus arteriosus in infants born very premature[J]. J Pediatr, 2024, 265: 113817. |
[8] | Clyman RI, Hills NK, Liebowitz M, et al. Relationship between duration of infant exposure to a moderate-to-large patent ductus arteriosus shunt and the risk of developing bronchopulmonary dysplasia or death before 36 weeks[J]. Am J Perinatol, 2020, 37(2): 216-223. |
[9] | Lin TY, Yeh JL, Hsu JH. Role of extracellular matrix in pathophysiology of patent ductus arteriosus: emphasis on vascular remodeling[J]. Int J Mol Sci, 2020, 21(13): 4761. |
[10] | Schneider DJ, Moore JW. Patent duct arteriosus[J]. Circulation, 2006, 114(17):1873-1882. |
[11] | Behbodi E, Villamor Martínez E, Degraeuwe PL, et al. Chorioamnionitis appears not to be a risk factor for patent ductus arteriosus in preterm infants: a systematic review and meta analysis[J]. Sci Rep, 2016, 6: 37967. |
[12] | Del Moral T, Gonzalez-Quintero VH, Claure N, et al. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants[J]. J Perinatol, 2007, 27(3):154-157. |
[13] | Qasim A, Jain SK, Aly AM. Antenatal magnesium sulfate exposure and hemodynamically significant patent ductus arteriosus in premature infants[J]. AJP Rep, 2019, 9(4): e353-e356. |
[14] | Yeung MY. Hypotension, persistent ductus arteriosus and the underlying adrenal insufficiency in low gestation newborns[J]. World J Pediatr, 2006, 2(1): 8-13. |
[15] | Corchia C, Da Frè M, Di Lallo D, et al. Mortality and major morbidities in very preterm infants born from assisted conception or naturally conceived: results of the area-based ACTION study[J]. BMC Pregnancy Childbirth, 2014, 14: 307. |
[16] | Gray KD, Saha S, Battarbee AN, et al. Outcomes of moderately preterm infants of insulin-dependent diabetic mothers[J]. Am J Perinatol, 2022, 27: 10.1055/a-1801-3050. |
[17] | de Klerk JCA, Engbers AGJ, van Beek F, et al. Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review[J]. Front Pediatr, 2020, 8: 541. |
[18] | de Carvalho Nunes G, Wutthigate P, Simoneau J, et al. Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes[J]. J Perinatol, 2022, 5: 642-648. |
[19] | Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics, 2020, 146(5): e20201209. |
[20] | Gentle SJ, Travers CP, Clark M, et al. Patent ductus arteriosus and development of bronchopulmonary dysplasia-associated pulmonary hypertension[J]. Am J Respir Crit Care Med, 2023, 207(7): 921-928. |
[21] | Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia[J]. Congenit Heart Dis, 2019, 14(1): 27-32. |
[22] | Obolonska OU. Perinatal risk factors and clinical features of hemodynamically significant patent ductus arteriosus in premature infants[J]. Modern pediatrics, 2020: 34-39. |
[23] | Tissot C, Singh Y. Neonatal functional echocardiography[J]. Curr Opin Pediatr, 2020, 32(2): 235-244. |
[24] | Yadav K, Hebert A, Lavie-Nevo K, et al. Targeted neonatal echocardiography for patent ductus arteriosus in neonates reduces the surgical ligation rate without affecting healthcare outcomes[J]. Transl Pediatr, 2023, 12(2): 137-145. |
[25] | 严梓, 陈春英, 杨奕清. 先天性动脉导管未闭致病基因MESP2新突变的发现与功能分析[J]. 国际心血管病杂志, 2003, 50(3): 170-174. |
/
〈 |
|
〉 |